These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38961817)
61. Review of management of laryngopharyngeal reflux disease. Lechien JR; Mouawad F; Bobin F; Bartaire E; Crevier-Buchman L; Saussez S Eur Ann Otorhinolaryngol Head Neck Dis; 2021 Sep; 138(4):257-267. PubMed ID: 33257265 [TBL] [Abstract][Full Text] [Related]
62. Change of signs, symptoms and voice quality evaluations throughout a 3- to 6-month empirical treatment for laryngopharyngeal reflux disease. Lechien JR; Finck C; Khalife M; Huet K; Delvaux V; Picalugga M; Harmegnies B; Saussez S Clin Otolaryngol; 2018 Oct; 43(5):1273-1282. PubMed ID: 29768736 [TBL] [Abstract][Full Text] [Related]
63. Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction. Wang AM; Wang G; Huang N; Zheng YY; Yang F; Qiu X; Chen XM Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2283-2287. PubMed ID: 31177327 [TBL] [Abstract][Full Text] [Related]
64. Combination of voice therapy and antireflux therapy rapidly recovers voice-related symptoms in laryngopharyngeal reflux patients. Park JO; Shim MR; Hwang YS; Cho KJ; Joo YH; Cho JH; Nam IC; Kim MS; Sun DI Otolaryngol Head Neck Surg; 2012 Jan; 146(1):92-7. PubMed ID: 21908799 [TBL] [Abstract][Full Text] [Related]
65. How to Understand and Treat Laryngopharyngeal Reflux. Snow G; Dhar SI; Akst LM Gastroenterol Clin North Am; 2021 Dec; 50(4):871-884. PubMed ID: 34717876 [TBL] [Abstract][Full Text] [Related]
66. Trial of transcutaneous electrical acupoint stimulation in laryngopharyngeal reflux disease: study protocol for a randomized controlled trial. Shen H; Han Y; Wu D; Hu L; Ma Y; Wu F; Tao Y; Liu Y Trials; 2022 Apr; 23(1):272. PubMed ID: 35395946 [TBL] [Abstract][Full Text] [Related]
67. The Use of Inhaled N-Acetylcysteine for Laryngopharyngeal Reflux Disease: A Randomized Controlled Trial. Jo YS; Choi IS; So YK J Voice; 2021 Jul; 35(4):618-624. PubMed ID: 31848062 [TBL] [Abstract][Full Text] [Related]
68. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes. Bobin F; Journe F; Lechien JR Laryngoscope; 2020 May; 130(5):1278-1281. PubMed ID: 31461170 [TBL] [Abstract][Full Text] [Related]
69. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients. Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659 [TBL] [Abstract][Full Text] [Related]
70. The importance of 24-h hypopharyngeal-esophageal impedance-pH monitoring for the treatment of laryngopharyngeal reflux. Baudouin R; Calvo-Henriquez C; Mayo-Yanez M; Iannella G; Maniaci A; Lechien JR Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5481-5482. PubMed ID: 36006517 [No Abstract] [Full Text] [Related]
71. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial. Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J Trials; 2016 Apr; 17():175. PubMed ID: 27036555 [TBL] [Abstract][Full Text] [Related]
72. Awareness about laryngopharyngeal reflux disease among Chinese otolaryngologists: a nationwide survey. Xiao S; Li J; Zheng H; Li X; Yang H; Zhang J; Peng X; Zhou S; Zhao C; Chen D; Xiao X; Shi L; Huangfu H; Tao Z; Chen X; Liu Y; Qu S; Wang G; Chen T; Cui X; Tian L; Zhou W; Fang H; Huang Y; Yu G; Lin Z; Tang L; He J; Ma R; Yu Z BMJ Open; 2022 Jun; 12(6):e058852. PubMed ID: 35732392 [TBL] [Abstract][Full Text] [Related]
73. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study. Boom L; Edens M; Rinia B Auris Nasus Larynx; 2020 Aug; 47(4):609-615. PubMed ID: 32113831 [TBL] [Abstract][Full Text] [Related]
74. Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease. Chiba T; Kudara N; Abiko Y; Endo M; Suzuki K; Sugai T; Ishijima K; Fukuda K; Yamazaki K; Sato H Hepatogastroenterology; 2011; 58(110-111):1580-2. PubMed ID: 21940324 [TBL] [Abstract][Full Text] [Related]
76. Symptoms classically attributed to laryngopharyngeal reflux correlate poorly with pharyngeal reflux events on multichannel intraluminal impedance testing. Salgado S; Borges LF; Cai JX; Lo WK; Carroll TL; Chan WW Dis Esophagus; 2022 Dec; 36(1):. PubMed ID: 35780323 [TBL] [Abstract][Full Text] [Related]
77. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Abou-Ismail A; Vaezi MF Curr Gastroenterol Rep; 2011 Jun; 13(3):213-8. PubMed ID: 21360069 [TBL] [Abstract][Full Text] [Related]
78. [Preliminary application of Dx-pH monitoring system in laryngopharyngeal reflux disease]. Han HL; Zhao JH; Zhang YL; Wang M; Wang HF; Cheng JN; Feng Y; Luo KQ; Lyu QP Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Sep; 51(9):666-670. PubMed ID: 27666704 [No Abstract] [Full Text] [Related]
79. New aspects in the pathomechanism and diagnosis of the laryngopharyngeal reflux-clinical impact of laryngeal proton pumps and pharyngeal pH metry in extraesophageal gastroesophageal reflux disease. Becker V; Drabner R; Graf S; Schlag C; Nennstiel S; Buchberger AM; Schmid RM; Saur D; Bajbouj M World J Gastroenterol; 2015 Jan; 21(3):982-7. PubMed ID: 25624734 [TBL] [Abstract][Full Text] [Related]
80. Laryngopharyngeal Reflux Patient Changes during the COVID-19 Quarantine. Rodriguez A; Steffens Y; Calvo-Henriquez C; Mayo-Yáñez M; Horoi M; Lechien JR Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629765 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]